Actually that's 100% wrong SubQ is the better method for all esters, but I've found out to avoid lumps all the time you don't pinch the area doing SubQ it causes an inflammatory response and 25 5/8 or 26 3/8 instead of slin pin. Slin pins are so small the basically cause inflammation with oils because of the small stream.
You actually can do a decent amount if done right, I was using an old method, subQ slows absorption.
Well, seems you are correct UserAt204. Found this single study:
New research conducted at the Royal Victoria Hospital in Canada at the endocrine clinic tested the viability of subcutaneous shots.
The study involved 22 patients who were using the clinic for testosterone replacement therapy. The AAS was testosterone enanthate. The subjects were instructed to self-administer their testosterone subcutaneously once per week. The same 1ml that would have been injected once every 2 weeks was divided up into .5ml weekly injections. Blood tests which were conducted periodically throughout the 1 year investigation were suprisingly and unquestionably consistent. For exactly 100% of patients enrolled, testosterone levels remained in the physiological (normal) range for the entire duration of the study. This included both peak and trough levels (high & low during each week). Furthermore injections were extremely well tolerated. Each patient took over 50 injections and not one single adverse reactionn was noticed at the injection site.
The investigation concluded that not only was subcutaneous testosterone enanthate a viable option as far as drug release , but it was safe, cheap and far more comfortable for their patients compared to intramuscular injections.
Well it may be unrealistic to inject a full throttle cycle via subcutaneous. Recall the patients were injecting .5ml a week. And we all know there are many aas users who far exceed this volume/dosage on a weekly basis. It also does not mean that every oil-based aas, even in low to moderate dosages, will be viable for subcutaneous. It is possible that some aas based on their preservatives, carriers, concentrations, or natural properties of active substances may be more irritating to local tissues when given subcutaneously.
Still the possibility of a subcutaneous cycle cannot be excluded especially for those using reasonable doses in the 1 ml range.
Saudi Med J, 2006 Dec;27(12):1843-6 courtesty of W. Llewellyn